132 related articles for article (PubMed ID: 29635619)
1. Ciprofloxacin and Rifampin Dual Antibiotic-Loaded Biopolymer Chitosan Sponge for Bacterial Inhibition.
Wells CM; Beenken KE; Smeltzer MS; Courtney HS; Jennings JA; Haggard WO
Mil Med; 2018 Mar; 183(suppl_1):433-444. PubMed ID: 29635619
[TBL] [Abstract][Full Text] [Related]
2. Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm.
Boles LR; Awais R; Beenken KE; Smeltzer MS; Haggard WO; Jessica AJ
Mil Med; 2018 Mar; 183(suppl_1):459-465. PubMed ID: 29635622
[TBL] [Abstract][Full Text] [Related]
3. Local control of polymicrobial infections via a dual antibiotic delivery system.
Tennent DJ; Shiels SM; Jennings JA; Haggard WO; Wenke JC
J Orthop Surg Res; 2018 Mar; 13(1):53. PubMed ID: 29544509
[TBL] [Abstract][Full Text] [Related]
4. Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.
Jennings JA; Beenken KE; Parker AC; Smith JK; Courtney HS; Smeltzer MS; Haggard WO
Macromol Biosci; 2016 Apr; 16(4):591-8. PubMed ID: 26756211
[TBL] [Abstract][Full Text] [Related]
5. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
6. Blended Chitosan Paste for Infection Prevention: Preliminary and Preclinical Evaluations.
Berretta JM; Jennings JA; Courtney HS; Beenken KE; Smeltzer MS; Haggard WO
Clin Orthop Relat Res; 2017 Jul; 475(7):1857-1870. PubMed ID: 28097503
[TBL] [Abstract][Full Text] [Related]
7. Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.
Li M; Neoh KG; Xu L; Yuan L; Leong DT; Kang ET; Chua KL; Hsu LY
Pharm Res; 2016 May; 33(5):1161-74. PubMed ID: 26792570
[TBL] [Abstract][Full Text] [Related]
8. Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
Shiels SM; Tennent DJ; Akers KS; Wenke JC
Injury; 2017 Oct; 48(10):2095-2100. PubMed ID: 28842287
[TBL] [Abstract][Full Text] [Related]
9. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection.
Inzana JA; Trombetta RP; Schwarz EM; Kates SL; Awad HA
Eur Cell Mater; 2015 Nov; 30():232-47. PubMed ID: 26535494
[TBL] [Abstract][Full Text] [Related]
10. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
11. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus.
Tan H; Peng Z; Li Q; Xu X; Guo S; Tang T
Biomaterials; 2012 Jan; 33(2):365-77. PubMed ID: 22014946
[TBL] [Abstract][Full Text] [Related]
12. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.
Aguilar-Colomer A; Doadrio JC; Pérez-Jorge C; Manzano M; Vallet-Regí M; Esteban J
J Antibiot (Tokyo); 2017 Mar; 70(3):259-263. PubMed ID: 27999440
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
15. Characterization of local delivery with amphotericin B and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation.
Parker AC; Beenken KE; Jennings JA; Hittle L; Shirtliff ME; Bumgardner JD; Smeltzer MS; Haggard WO
J Orthop Res; 2015 Mar; 33(3):439-47. PubMed ID: 25408519
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
17.
Fletcher J; Porter R; Boulton Z; Brown L; Knight B; Romanczuk L; Aiken S; Delury C; Michell S
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35604937
[No Abstract] [Full Text] [Related]
18. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.
Kucukoglu V; Uzuner H; Kenar H; Karadenizli A
Int J Pharm; 2019 Oct; 569():118578. PubMed ID: 31362096
[TBL] [Abstract][Full Text] [Related]
20. Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.
Noel SP; Courtney HS; Bumgardner JD; Haggard WO
Clin Orthop Relat Res; 2010 Aug; 468(8):2074-80. PubMed ID: 20352389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
